Risperdal, a drug used to treat several physiological and neurological problems is the target of numerous Rispderal lawsuits alleging the drug can cause gynecomastia, or “man boobs.”
Risperdal began its clinical life as an atypical antipsychotic, a second-generation drug designed to treat schizophrenia. But many drugs designed to treat diseases of the brain find other uses. For example, seizure medicines may be found to work as antidepressants. Along similar lines, researchers discovered that Risperdal could help treat bipolar disorder and some symptoms associated with autism.
In many forms of autism, aggression and irritability are present. Risperdal was eventually approved to treat this aggression and irritability. Studies have suggested that the drug can help calm people with autism without leaving them drugged like a sedative would. However, concerns of serious Risperdal side effects have been raised.
Studies have suggested that Risperdal side effects could include male breast growth. Researchers have suggested Risperdal can increase a person’s level of prolactin, a hormone that regulates breast growth in females.
However, excessive prolactin levels in males can lead to male breast growth, or gynecomastia. This side effect is most pronounced in younger males who took Risperdal during their childhood and teens, but new studies are suggesting the effect could be seen throughout life.
Concerns of Risperdal side effects have put the drug at the center of Risperdal lawsuits. These Risperdal lawsuits have taken the form of a Risperdal MDL, a sort of coordinated group of similar lawsuits. MDLs are similar, in some ways, to class action lawsuits.
Both class action lawsuits and MDLs are designed to help streamline the legal process by combining tens, hundreds, or even thousands, of potential individual lawsuits into a single coordinated legal process. The main difference is that class action lawsuits are started as group lawsuits, while MDLs start out as a number of similar individual cases.
The Risperdal MDL is In re: Risperdal Litigation, Case No. 100300296, in the Philadelphia Court of Common Pleas.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Risperdal attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Risperdal class action lawsuit is best for you. [In general, Risperdal lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2026 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Invega or Risperdal Class Action Lawsuit Investigation
If you or your son took Invega or Risperdal between the ages of 10 and 18 years old and suffered gynecomastia (male breast growth), male breast pain, nipple pain, or nipple discharge, you may be entitled to compensation. See if you qualify by submitting your information below for a free and confidential case review.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
Please Note: If you want to participate in this investigation, it is imperative that you reply to the law firm if they call or email you. Failing to do so may result in you not getting signed up as a client, if you qualify, or getting you dropped as a client.
Oops! We could not locate your form.
